Biobank Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Biobank Market – Report Overview

Pacific Business Consulting’s “Biobank Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Biobank market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Biobank market exceeded a valuation of over US$ 70.0 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 7.0% from 2023 to 2030. The market is expected to potentially surpass US$ 110.0 Billion by 2030.

The market is experiencing significant growth driven by the increasing popularity of precision/personalized medicine and genetic testing. Biobanks, integral to biomedical research, have played a crucial role in this progression. Advances in platforms and tools for genetic studies have spurred demand for biospecimens from clinical labs for genetic testing assays. Collaborations between private and public institutions in biobanking have further propelled market advancement.

Digitalization, precision medicine, and virtualization are transforming the biobanking industry through innovative methods and synergies initiated by public and private organizations. Collaborations with biobanks by companies across various sectors are accelerating market revenue. In October 2023, for example, UK Biobank secured USD 34.5 million in funding through a partnership with several philanthropists.

The exponential increase in global cases, especially during the COVID-19 pandemic, has underscored the importance of biobanks in containing the virus. Biobanks serve as vital repositories for high-quality COVID-19 specimens, supporting both research and diagnostic purposes. The outbreak has increased demand for biobank services, with institutions like Tulane University establishing COVID-19 biobanks to aid research efforts.

Key factors contributing to the growth of the biobank market include innovations in regenerative medicine, the rising incidence of chronic diseases, advances in drug discovery and development, and government and non-governmental organizations’ investments in R&D. Government initiatives and clinical trials associated with stem cell research, as seen with the Indian Council of Medical Research (ICMR) guidelines, highlight the growing support for ethical and scientific stem cell research.

In the sports domain, collaborations such as the NFLA and Sanford Health biobank construction aim to advance regenerative medicine, focusing on sports-related injuries, brain health, and sports performance. Acquisitions like Gaensel Energy Group Inc.’s purchase of SSCB Swiss Stem Cells Biotech SA, which specializes in preserving stem cells from adipose tissue, contribute to regenerative medicine’s potential.

Developing countries in the Middle East, exemplified by the Crown Prince of Abu Dhabi’s announcement of a biobank, are investing in biobanks to advance medical research. This initiative supports personalized medicine through advanced treatments utilizing human tissues and stem cells, positioning the UAE prominently in the global biobanks market.

High investments in advanced therapy R&D, including regenerative medicine, personalized medicine, and cancer genomic studies, are key drivers shaping the biobank market’s growth trajectory.

Leading players in the Biobank segment, including BioLifeSolutions Inc., Hamilton Company, Merck KGaA (Sigma-Aldrich Inc.), Thermo Fisher Scientific Inc., and Avantor (VWR International LLC), Biocision, LLC., Taylor-Wharton, Charles River Laboratories; Lonza, Stemcell Technologies, Biovault Family, and Promocell Gmbh, are expected to play a crucial role in shaping the future landscape of Biobank technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Biobank market. It also delves into the analysis of present and prospective market competition within the global Biobank market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Biobank market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Biobank market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Biobank
   • Global Market Outlook: Biobank
2. Competitive Intelligence Analysis: Biobank
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Biobank
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Biobank
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Biobank: Ten Major Market (10MM) – Market Analysis, By Product
   • Temperature Control Systems
   • Incubators & Centrifuges
   • Alarms & Monitoring Systems
   • Biobanking Consumables
   • Laboratory Information Management Systems
9. Biobank: Ten Major Market (10MM) – Market Analysis, By Biospecimen Type
   • Human Tissue
   • Cord
   • DNA/RNA
   • Stem Cell
   • Others
10. Biobank: Ten Major Market (10MM) – Market Analysis, By Application
    • Drug Discovery & Clinical Research
    • Regenerative Medicine
    • Therapeutics
    • Others
11. Biobank: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

12. S. Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

13. K. Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

14. Germany Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

15. France Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

16. Italy Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

17. Spain Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

18. Japan Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

19. China Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

20. Australia Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

21. India Biobank – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Biospecimen Type
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Biospecimen Type
      • By Application

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer